Form 4: Axon Enterprise COO & CFO, Brittany Bagley, Executes Stock Sales Under 10b5-1 Plan

Axon Enterprise's COO & CFO, Brittany Bagley, sold a total of 6,325 shares of common stock on November 15, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Brittany Bagley, the COO & CFO of Axon Enterprise, Inc., sold 6,325 shares of common stock on November 15, 2024.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 16, 2024.
• The transactions occurred in multiple trades at varying prices, with weighted average prices reported for each block of sales.
• The sales prices ranged from $596.446 to $600.88 per share.
• Following these transactions, Ms. Bagley directly owns 80,135 shares of Axon common stock.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock sales by an executive under a pre-arranged plan, which is neither positive nor negative in itself.

Risks

• While the sales were pre-planned, large sales by executives can sometimes be perceived negatively by the market.

Industry Context

Executive stock sales are a common occurrence, especially under pre-arranged trading plans like Rule 10b5-1, and are often a part of executive compensation packages. This filing is a routine disclosure of such activity.

Comparison to Industry Standards

• Rule 10b5-1 trading plans are a standard practice among publicly traded companies to allow insiders to sell shares without concerns about insider trading violations.
• The reported sales are consistent with typical executive stock transactions and are not unusual in the context of the broader market.
• Other companies such as Microsoft, Apple, and Google also have executives who use 10b5-1 plans to manage their stock sales.

Stakeholder Impact

• The stock sales may have a minor impact on the stock price, but the pre-planned nature of the sales should mitigate any significant negative reaction.

Key Dates

Keywords

Axon Enterprise, Brittany Bagley, insider trading, Form 4, stock sale, Rule 10b5-1, executive compensation, corporate governance